Monday, June 15, 2026

Samsung Electronics Rallies as Foreign Investors Pour In $750 Million Despite U.S. Chip Selloff

Samsung Electronics defied falling U.S. semiconductor stocks, rising nearly 3% as foreign investors bought $750 million in shares.

Humedix Seeks Domestic Approval for PN-HA Composite Filler Valpien

Huons Group's Humedix is set to launch Valpien, a novel composite filler, improving wrinkle treatment with less pain and effective results.

HanmiGlobal Secures Major IDIQ Contract for Infrastructure Projects with U.S. National Park Service

HanmiGlobal's U.S. subsidiary, OTAK, wins a key contract with the National Park Service for infrastructure upgrades across national parks.

Tag: NK cell therapy

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

NK Cell Cancer Therapies Move Closer to Market as Matica BioLabs Partners With Ingenium

CHA Biotech's Matica BioLabs partners with Ingenium Therapeutics for NK cell therapy production, targeting cancer treatment advancements.

Top News

- Our Sponsors Ad -

Follow us